SGX Pharmaceuticals to Present at the BIO Investor... ( SAN DIEGO Oct. 3 /- SGX Pharmaceu...)

SGX Pharmaceuticals to Present at the BIO InvestorForum 2007

Date:10/3/2007

SAN DIEGO, Oct. 3 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals, Inc. (Nasdaq: SGXP) will be presenting at the BIO InvestorForum on October 10, 2007, at 1:00 p.m. Pacific Daylight Time. Mike Grey, president and chief executive officer of SGX Pharmaceuticals, will provide an overview of the Company's oncology pipeline. The conference is being held October 9th through the 11th at the Palace Hotel in San Francisco.

A live webcast of the presentation will be available under the investor relations section of the Company's website at http://www.sgxpharma.com. Replays of the presentation will be available for 90 days following the event. Please connect to the Company's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About SGX Pharmaceuticals

SGX Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics. The SGX oncology pipeline includes drug candidates from its enabling, proprietary FAST(TM) drug discovery platform, such as next generation BCR-ABL inhibitors, MET tyrosine kinase inhibitors, including SGX523, and potent JAK2 inhibitors. More information on the pipeline and drug discovery platform can be found at http://www.sgxpharma.com and in the Company's various filings with the Securities and Exchange Commission.

SOURCE SGX Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:12/5/2009)WASHINGTON, Dec. 5 ,, What: Cuts for a Cause ,, Why: To make a difference in the fight against cancer and other terminal illnesses affecting children. All proceeds from each hair service given

(Date:12/5/2009)... , , SATURDAY, Dec. 5 (HealthDay News) -- ...d asthma can have bad reactions to certain holiday...ent sneezing and wheezing, according to the Americ...I). , Those who are allergic to live evergreens ma...oth live and artificial trees can trigger symptoms...

(Date:12/5/2009)The MAMA campaign is a collaborative effort by the National Association of Certified Professional Midwives (NACPM), Midwives Alliance of North America (MANA), Citizens for Midwifery (CfM), Internation

(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s

(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th

Breaking Medicine News(10 mins):Health News:Keep Asthma, Allergies at Bay for the Holidays 2 Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2 Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3 Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4 Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2 Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2

[0] Salon Leau to Host 'Cuts for a Cause' to Raise Funds and Spread the Word About Childhood Terminal Illnesses [0] Keep Asthma, Allergies at Bay for the Holidays [0] AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign [0] KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children [0] Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana

...identified particular genes that are most prone to... called DNA promoter hypermethylation. Hy...ch support normal cell development, to generate pr...anism and causes of hypermethylation, particularly...

...ion between an extreme form of sleep disorder, REM...mentia or parkinsonism. Patients with RBD...body dementia, Parkinsons disease or multiple syst... of researchers led by Bradley Boeve at Mayo Clini...

...husiasts and experts in the capital are strongly o... Reacting to recent reports of yet another appl...s here feel that the very idea of patenting knowle...nal. The entire issue of patenting is very corpora...

...verage for mental illness does not increase usage ...s who have children with mental illness, a Yale S...lth Services Research. Prior research has ...t professor in the Department of Epidemiology & Pu...

... dangers of the rugby scrum could be a key reason ...uffered by rugby players, says a researcher writi...s, although rare, are a major cause of permanently...by Union in partnership with the Accident Compensa...

...r quacks either. A team of researchers in Pennsylv... follicles . And they have successfully created n...nal Nature, they say hair growth can actually be e...hese follicles are produced by the embryo in the f...

Other Medicine News:Health News:Researchers Have Identified Cancer Promoter Genes 2 Health News:Researchers Find Link Between Sleep Disorder and Dementia 2 Health News:Yoga Enthusiasts Oppose Patenting Yoga Overseas 2 Health News:Coverage for Childrens Mental Illness Reduces Out-of-Pocket Spending 2 Health News:Innovative Education Scheme Sees Fewer Rugby Players Suffering Spinal Injuries 2 Health News:It is Possible Reverse Hair Loss, US Scientists Say 2

Researchers Have Identified Cancer Promoter Genes Researchers Find Link Between Sleep Disorder and Dementia Yoga Enthusiasts Oppose Patenting Yoga Overseas Coverage for Childrens Mental Illness Reduces Out-of-Pocket Spending Innovative Education Scheme Sees Fewer Rugby Players Suffering Spinal Injuries It is Possible Reverse Hair Loss, US Scientists Say

(Date:12/3/2009)ACTON, Mass., Dec. 3 Allen Medical Systems, a subsidiary of Hill-Rom Holdings, Inc. (NYSE: HRC ), today announced the launch of its new Allen Amatech(TM) OEM (Original Equipment Manufacturer) busin

(Date:12/3/2009)MADISON, N.J., Dec. 3 A genetic variation that may indicate a patient,s risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is

(Date:12/3/2009)DOYLESTOWN, Pa., Dec. 3 Ted Karkus, Chairman and CEO of The Quigley Corporation, (Nasdaq: QGLY ) www.quigleyco.com announced today that the Company has completed its evaluation of its opportunitie

Breaking Medicine Technology:Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2 Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2 Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3 Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2 Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3 Your Surroundings Mirror Your Beliefs 50509 1 Your Surroundings Mirror Your Beliefs 50509 2 Your Surroundings Mirror Your Beliefs 50509 3 Morphotek 28R 29 Inc Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and 12866 1 Morphotek 28R 29 Inc Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and 12866 2 Morphotek 28R 29 Inc Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and 12866 3 eCardio Receives Significant Investment in Private Funding from Sequoia Capital 50507 1 eCardio Receives Significant Investment in Private Funding from Sequoia Capital 50507 2

[0] Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website [0] Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition [0] Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution

SpineMark Partners With Regional Spine Leaders to Launch Its First Multisite Spine Research Organizations in Los Angeles, Denver

Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008

Other Medicine Technology:SpineMark Partners With Regional Spine Leaders to Launch Its First Multisite Spine Research Organizations in Los Angeles, Denver 2 SpineMark Partners With Regional Spine Leaders to Launch Its First Multisite Spine Research Organizations in Los Angeles, Denver 3 Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008 2 Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008 3 Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008 4

SpineMark Partners With Regional Spine Leaders to Launch Its First Multisite Spine Research Organizations in Los Angeles, Denver Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008

...agnostics Histoplasma DxSelect is intended for qua...sulatum var. capsulatum in human serum. The test i... respiratory disease, as an aid in the presumptive...is test is not intended for self-testing, and this...

...unofluorescent antibody (IFA) test for the detecti...dies to St. Louis Encephalitis (SLE), Western Equi... (EEE), and California Encephalitis/La Crosse (CE)...s with fixed individual spots of SLE, WEE, EEE, an...

Epstein-Barr Nuclear Antigen (EBNA) ACIF (Anti-Complement Immunofluorescence)

CMF OL1000 Bone Growth Stimulators

Medicine Products:

Histoplasma DxSelect Arbovirus IFA IgM Epstein-Barr Nuclear Antigen (EBNA) ACIF (Anti-Complement Immunofluorescence)CMF OL1000 Bone Growth Stimulators

SGX Pharmaceuticals to Present at the BIO Investor...( SAN DIEGO Oct. 3 /- SGX Pharmaceu...),Health